Cargando…

Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland

BACKGROUND: Large-scale data on type-specific HPV prevalences and disease burden are needed to monitor the impact of HPV vaccination and to plan for HPV-based cervical screening. METHODS: 33 043 women (aged 25–65) were screened for HPV by a Hybrid Capture 2 (HC2) in a population-based programme. HPV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leinonen, M K, Anttila, A, Malila, N, Dillner, J, Forslund, O, Nieminen, P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844908/ https://www.ncbi.nlm.nih.gov/pubmed/24136148 http://dx.doi.org/10.1038/bjc.2013.647

Ejemplares similares

Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland
por: Leinonen, Maarit K, et al.
Publicado: (2012)

Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland
por: French, K M, et al.
Publicado: (2007)

High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders
por: Lam, J U H, et al.
Publicado: (2018)

Effectiveness of screening for colorectal cancer with a faecal occult-blood test, in Finland
por: Pitkäniemi, J, et al.
Publicado: (2015)

Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a cross-sectional study
por: Hibbitts, S, et al.
Publicado: (2008)

Piloting gender-oriented colorectal cancer screening with a faecal immunochemical test: population-based registry study from Finland
por: Sarkeala, Tytti, et al.
Publicado: (2021)

Effect of hysterectomy on incidence trends of endometrial and cervical cancer in Finland 1953–2010
por: Luoto, R, et al.
Publicado: (2004)

Overdiagnosis due to breast cancer screening: updated estimates of the Helsinki service study in Finland
por: Heinävaara, S, et al.
Publicado: (2014)

Cervical cancer mortality in Norway according to screening attendance and age
por: Baasland, Ingrid, et al.
Publicado: (2022)

Cumulative risk of false positive test in relation to breast symptoms in mammography screening: a historical prospective cohort study
por: Singh, Deependra, et al.
Publicado: (2016)

Understanding cervical screening non-attendance among ethnic minority women in England
por: Marlow, L A V, et al.
Publicado: (2015)

The costs of offering HPV-testing on self-taken samples to non-attendees of cervical screening in Finland
por: Virtanen, Anni, et al.
Publicado: (2015)

Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme
por: Anttila, Ahti, et al.
Publicado: (2010)

Association of symptoms and breast cancer in population-based mammography screening in Finland
por: Singh, Deependra, et al.
Publicado: (2015)

Colposcopy attendance and deprivation: A retrospective analysis of 27 193 women in the NHS Cervical Screening Programme
por: Douglas, E, et al.
Publicado: (2015)

A population-based study on the risk of cervical cancer and cervical intraepithelial neoplasia among grand multiparous women in Finland
por: Hinkula, M, et al.
Publicado: (2004)

Cervical human papillomavirus and HIV infection in women of child-bearing age in Abidjan, Côte d’Ivoire, 2010
por: Jaquet, A, et al.
Publicado: (2012)

Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway
por: Burger, E A, et al.
Publicado: (2012)

Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing
por: van Rosmalen, J, et al.
Publicado: (2012)

Cervical cancer screening programmes and policies in 18 European countries
por: Anttila, A, et al.
Publicado: (2004)

Opportunistic HPV vaccination at age 16–23 and cervical screening attendance in Sweden: a national register-based cohort study
por: Kreusch, Teresa, et al.
Publicado: (2018)

Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya
por: De Vuyst, H, et al.
Publicado: (2012)

Comparison of human papillomavirus‐based cervical cancer screening strategies in Tanzania among women with and without HIV
por: Kahesa, Crispin, et al.
Publicado: (2022)

Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20–29 in the UK
por: Cuzick, J, et al.
Publicado: (2010)

Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening
por: Bulkmans, N W J, et al.
Publicado: (2005)

Age-specific and genotype-specific carcinogenic human papillomavirus prevalence in a country with a high cervical cancer burden: results of a cross-sectional study in Estonia
por: Pärna, Kersti, et al.
Publicado: (2023)

Overdiagnosis among women attending a population-based mammography screening program
por: Falk, Ragnhild Sørum, et al.
Publicado: (2013)

Frequency of Human papillomavirus in women attending cervical cancer screening program in Chile
por: Brebi, Priscilla, et al.
Publicado: (2017)

Human papillomavirus infection in women who develop high-grade cervical intraepithelial neoplasia or cervical cancer: a case–control study in the UK
por: Grainge, M J, et al.
Publicado: (2005)

A cervical screening initiative for elderly women in Denmark
por: Skorstengaard, Malene, et al.
Publicado: (2023)

Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial
por: Lehtinen, Matti, et al.
Publicado: (2021)

Validation of the cobas 6800 human papillomavirus test in primary cervical screening
por: Sundström, Karin, et al.
Publicado: (2021)

Differences in the risk of cervical cancer and human papillomavirus infection by education level
por: Franceschi, S, et al.
Publicado: (2009)

Papillomavirus infection in rural women in southern India
por: Franceschi, S, et al.
Publicado: (2005)

Cervical cancer case–control audit: Results from routine evaluation of a nationwide cervical screening program
por: Wang, Jiangrong, et al.
Publicado: (2019)

Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study
por: Bjørge, T, et al.
Publicado: (2002)

Benefit of cervical screening at different ages: evidence from the UK audit of screening histories
por: Sasieni, P, et al.
Publicado: (2003)

Benefits and harms of cervical screening from age 20 years compared with screening from age 25 years
por: Landy, R, et al.
Publicado: (2014)

Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen‐detected cervical precancer
por: Inturrisi, Federica, et al.
Publicado: (2020)

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
por: Clifford, G M, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_p13o4namh3rkn7jvufs3ahf4b2